Abbott Laboratories fined $1.6bn for Depakote marketing
The pharmaceutical company marketed its anti-seizure medication as being suitable for things it had not been authorised for
Finance & Insurance - Abbie Smith
Doctors are unhappy with career choice as salaries fall
According to an annual survey conducted by Medscape, only 50 percent of doctors said they would choose medicine as a career path again
AstraZeneca CEO David Brennan to retire in June
The company's Chairman, Louis Schweitzer, has also announced his retirement three months early than expected
AstraZeneca buys Ardea Biosciences for $1.26 billion
The pharmaceutical giant is hoping to boost its product line with Ardea's experimental drug treatments for gout and cancer
New 5p and 10p coins could cause dermatitis and eczema
Dermatologists are warning that a change to the coating of the new coinage will aggravate common skin conditions and allergies
Patent Box legislation aims to boost UK's R&D industry
The UK government is hoping to re-establish the UK's position as a world leader in patented innovation
'Chinplants' are newest cosmetic surgery trend in US
Figures released by the American Society of Plastic Surgeons have revealed that 20,680 chin augmentations were carried out in America during 2011 - a 71 percent increase from 2010
Pharma giants lose out in urological disorders market
The expiration of a number of patents on key drugs will prove to be challenging for major pharmaceutical companies
UK to boost dementia research funding to £66m by 2015
It comes days after a study revealed that the UK was one of the world's leaders in dementia research
Microsoft co-founder pledges $300m to brain research
Paul Allen will invest the sum over the next three years in the Allen Institute for Brain Science
